Keynote by Sangita Reddy Joint Managing Director Apollo Hospitals India AI Impact Summit

20 Feb 2026 16:00h - 17:00h

Keynote by Sangita Reddy Joint Managing Director Apollo Hospitals India AI Impact Summit

Session at a glanceSummary, keypoints, and speakers overview

Summary

Dr. Pratap Siredi opened the talk by emphasizing that health care in India must be accessible regardless of zip code and that sustainable costs, preventive care, and early detection are essential to a new collaborative paradigm, leveraging the country’s large out-of-pocket market, expanding medical workforce, and extensive AI talent pool [1-4][8-9]. He described Apollo’s mission to bring advanced technology to patients, noting that the organization has integrated surgical robots, proton therapy, and a digital front door called Apollo 24-7 that lets users purchase medicines, order diagnostics, store records, and interact with an AI assistant [10-13].


Apollo 24-7 now serves over 45 million registered users with nearly one million daily interactions, and its services reach more than 1,100 towns and cities across India, extending beyond major urban centers [14-18]. The company’s AI platform, which has processed about 3.5 million API calls, is organized into five work streams that include a clinical intelligence engine, a decision-support system built on 20 million doctor records, disease-risk scoring for a 1.4 billion-person population, multimodal imaging analysis, and acute-care pathways that predict sepsis 24-48 hours in advance [19-24][25-32]. Additional AI capabilities aim to optimise throughput by automating billing, reducing patient wait times, and auto-populating records, with many tools already receiving MDSAP and FDA approvals [33-38].


To ensure responsible use, Apollo published the EASE framework, which addresses ethical adoption, suitability, and explainability of AI algorithms for health-care workers [40-43]. The speaker highlighted preventive initiatives such as an embedded-AI ultrasound that detects non-alcoholic fatty liver disease, a pre-diabetes algorithm already applied to 450 000 people, and collaborations with Google to identify tuberculosis from chest X-rays, all aimed at early disease interception [45-48][58-62][63-66]. A clinician-co-pilot tool that synthesises patient records is reported to save one to one-and-a-half hours of physician time per day, and a nurse-pilot version is being rolled out to further reduce workload [72-74].


Rural outreach includes mobile vans for non-communicable disease and cancer screening, tele-ophthalmology, and data sharing with ASHA workers and district health authorities to enable faster, cheaper diagnoses [79-82]. Apollo stresses that extensive validation-more than any other Indian health-care entity-is essential to move pilots into mainstream practice and to build trust among research, pharma, and manufacturing partners [83-85]. Looking ahead, the vision is an interconnected health system that links public and private sectors, primary and advanced care, research institutions, and health-tech startups, creating a flywheel that drives productivity, economics, and new predictive algorithms [86-93].


The speaker concluded by calling for collective action to close skill and regulatory gaps, make health care predictive, preventive, personalized, participatory, and place-agnostic, and to ensure every village, city, or apartment can access quality clinical care [94-99]. He ended with a hopeful note that this collaborative effort can accelerate cures for cancer and build a healthier future for the next generation [100].


Keypoints


Major discussion points


A national AI-driven health-care ecosystem anchored in India’s unique advantages – the speaker highlights India’s large out-of-pocket market, rapid growth of doctors and nurses, and a talent pool of over 600,000 AI engineers as the foundation for a new, cost-effective, preventive-care paradigm that reaches every zip code [1-5][9-12][16-18].


A multi-layered AI platform with concrete use-cases – Apollo has built five AI work streams (clinical intelligence engine, workforce analytics, disease-risk prediction, multimodal imaging & signal interpretation, and acute-care pathways). Examples include early-warning sepsis prediction 24-48 hours in advance, AI-assisted radiology for TB and brain bleed, and throughput optimisation that saves clinician time [19-35][30-34][38][64-66][72-74].


Ethical, explainable AI governance – the “EASE” framework (Ethical, Adoption, Suitability, Explainability) is presented as a baseline for any health-care AI deployment, ensuring clinicians understand and trust algorithmic outputs [40-44].


Preventive health and population-scale screening – AI tools for diabetes risk, NAFLD detection via ultrasound, and lifestyle risk scoring are being deployed at scale (e.g., 450 k users of a pre-diabetes algorithm). Mobile vans, tele-ophthalmology, and ASHA-worker integration extend these capabilities to rural India [44-62][80-82].


Vision of an interconnected “health system of the future” – beyond hospital walls, the speaker calls for a unified network linking public and private sectors, primary and advanced care, research institutions, startups, and even drone logistics, to create a predictive, preventive, personalized, participatory, place-agnostic health ecosystem [85-92][95-98].


Overall purpose / goal


The speaker’s primary aim is to share Apollo Hospitals’ story of leveraging AI and digital tools to make high-quality health care affordable and accessible across India, demonstrate concrete innovations and their impact, and rally partners (researchers, pharma, tech firms, regulators) to collaborate in building a future health system that is preventive, data-driven, and universally reachable.


Overall tone


The discussion is consistently upbeat, confident, and visionary. It blends inspirational language (“a thousand flowers can bloom,” “let us dream of finding cures”) with detailed technical examples, maintaining an enthusiastic and persuasive tone throughout without noticeable shifts to a more somber or critical mood.


Speakers

Speaker 1


Name: Dr. Pratap Siredi


Role/Title: Chairman, Apollo Hospitals (Apollo Group)


Area of Expertise: Healthcare delivery, AI‑enabled health services, preventive and personalized medicine


Additional speakers:


None identified


Full session reportComprehensive analysis and detailed insights

The talk opened with Dr Pratap Siredi, Chairman of Apollo Hospitals, who recalled that his father founded the first Apollo hospital after returning from the United States roughly 43 years ago, underscoring the family legacy that underpins the organisation’s mission [1-2]. He asserted that health-care in India must be a right that does not depend on the zip code of birth, emphasizing sustainable costs, preventive care and early detection as the foundation of a new collaborative paradigm [3-5].


He then outlined India’s systemic advantages: a large out-of-pocket payment market, rapid expansion of doctors and nurses, and a talent pool of more than 600 000 AI engineers that together provide the scale and affordability needed to build a national, AI-driven health-care ecosystem [6-9][10-12].


To operationalise this vision, Apollo has created a digital front-door called Apollo 24-7, an integrated patient portal where users can purchase medicines, order diagnostics, store health records and interact with an AI assistant (Apollo Assist) [13-15]. The platform now hosts over 45 million registered users and sees close to one million daily interactions, demonstrating strong market adoption and scalability [16-18].


Underlying Apollo 24-7 is a multi-layered AI platform organised into five work streams [19-20].


1. Clinical intelligence engine – supplies new doctors with the collective knowledge of 20 million clinician records, forming a robust decision-support system [21-23].


2. Disease-risk prediction – generates population-level risk scores for a 1.4-billion-person cohort, targeting cardiac disease, diabetes and hypertension [24-26].


3. Multimodal imaging & signal analytics – extracts insights from imaging and physiological data, synthesising information more effectively than any single clinician [27-28].


4. Acute-care pathways – includes an early-warning system that predicts sepsis 24-48 hours before onset across 2 000 critical-care beds, with the speaker noting the potential impact of scaling to 100 000 ICU beds [29-33].


5. Throughput optimisation – automates billing, reduces patient wait times and auto-populates records, thereby freeing clinician capacity [34-36].


Regulatory progress is substantial, with approximately 19 tools receiving MDSAP approval and nine securing FDA clearance, underscoring the emphasis on safety and efficacy [37-38]. Following this, the speaker invited collaborators, stating “we’re looking for partnership to build because I believe in this space” [39].


He introduced the EASE framework – Ethical, Adoption, Suitability, Explainability – as a baseline governance model to ensure AI deployments are transparent, appropriate for the clinical context and understandable to health-care workers [40-43].


Preventive-care initiatives were highlighted. An embedded-AI module in ultrasound machines can detect non-alcoholic fatty liver disease (NAFLD) early, potentially averting liver transplantation for millions [44-46]. A pre-diabetes AI product, already applied to 450 000 individuals, is envisioned to scale to the estimated 85 million diabetics in India [47-51]. Lifestyle-risk scoring tools, developed with Solventum and 3M, quantify risk profiles and guide personalised interventions, moving beyond generic social-media health advice [52-57]. The speaker quantified the preventive impact, noting that screening 1 000 people averts major crises in 11 of them [58-59].


In radiology, collaborations with Google enable AI-based tuberculosis detection from chest X-rays, while other partners support rapid identification of brain bleeds, facilitating swift emergency care [60-63].


The clinician co-pilot synthesises patient records, saving physicians 1-1.5 hours per day [64-66]; a parallel nurse pilot will extend these time-saving benefits to nursing staff [67-68].


Acute-care monitoring is further advanced through the Care Console, which integrates ICU and home-ward data, and the envisioned use of drone delivery to transport medicines and diagnostics as part of the “hospital of the future” concept [69-71].


Rural outreach forms a critical pillar of the strategy. Mobile vans conduct non-communicable disease and cancer screening, tele-ophthalmology services reach remote populations, and data are shared with ASHA workers and district health authorities to enable faster, cheaper diagnoses [72-74].


Apollo positions itself as one of India’s most active validators of AI pilots, recognising that rigorous validation is essential to transition innovations from proof-of-concept to mainstream practice [75-77].


Looking ahead, the speaker reframed the “hospital of the future” as an interconnected health system linking public and private providers, primary and advanced care, research institutions, universities and health-tech startups [78-82]. He described this network as a “flywheel” that drives productivity, economic sustainability and the development of new predictive and preventive algorithms [83-84]. The vision is a health ecosystem that is predictive, preventive, personalised, participatory and place-agnostic, capable of delivering high-quality care to any village, city or apartment [85-89].


In conclusion, the speaker called for collective action to close skill gaps, accelerate regulatory pathways and unite companies, organisations and individuals in building this new health-care world [90-92]. He urged that every community, regardless of location, should have access to good clinical care and expressed optimism that such collaboration could hasten cures for cancer and secure a healthier future for the next generation [93-95].


Session transcriptComplete transcript of the session
Speaker 1

India and that your health care should not be defined by the zip code in which you’re born. It’s about sustainable costs and it’s about preventive care and early detection. It’s a new paradigm in collaborative care where I believe India has an advantage. This advantage is because we not only have one of the highest out -of -pocket payment and therefore we’re creating innovation and keeping our costs low, but also we’re growing more doctors, we’re training more nurses, and we have the largest talent pool of over 600 ,000 AI engineers. All this coming together to create something truly significant. But I’m not here to talk to you about technology. I’m here to share our story. And this story is about using the passion and the mission of bringing health care within the reach of people and using every tool possible to enable this to happen.

Dr. Pratap Siredi. I’m the art chairman and I’m honored to say my father. brought to polar hospitals when he returned from the U .S. almost 43 years ago to bring this, to bring healthcare within the reach of people. Today, we’ve tried to embed and imbibe every technology, whether it’s surgical robots, the proton therapy, all kinds of treatment and curative capability. We’ve gone beyond to say we must find a way to not just use these machines, but also to connect with our customer. So Apollo 24 -7, our digital front door, is actually, not only can you buy your medicines, order your diagnostics, store your health record, but also on Apollo Assist, ask queries, questions, get these answered, and then find ways.

And our market has rewarded us with the volumes that we see. Over 45 million users have come into this. and now we have close to a million users on a daily basis coming in to interact on this ecosystem. These records, these capabilities are getting enhanced every day because of the power of the communications that we have. But moving on, I think what is most important is that we’re not just in the big cities. We’re serving multiple PIN codes across the country and over 1 ,100 towns and cities. Moving across divine methodologies, I just wanted to share with you quickly a few of the things that we’re doing in AI because this is the AI summit. And approximately now we have about 3 .5 million API calls on our AI platforms.

These platforms we’ve divided into five areas. Number one is really our clinical intelligence engine so that a new doctor can have the knowledge and the capability of the cumulative data that we’re providing to the patient. And number two is the cumulative doctor workforce of about 20 million records analyzed. So this is our clinical decision support and our clinical intelligence engine. The next one is the disease prediction and the risk score, because we need to know in a population of 1 .4 billion people, where do we focus? What should we do more? So this is the second work stream, and this goes across cardiac, diabetes, multiple others, including hypertension, but we’re also looking at embedded AI. The next and another critical one is taking images and signals, because the body is an amazing piece of machinery that continues to give us this messaging.

How do we pick this up, synthesize it smarter than any one individual can do, and bring this multimodal signaling into a causal interpretation to thereby enable the doctor. We also have acute care augmented pathways. About 2 ,000 of our critical care beds are connected with our early warning symptom, and there we are predicting. The onset of sepsis. 24 to 48 hours before it happens. Imagine if we could take this AI algorithm and put it into a hundred thousand ICU beds. Imagine the number of lives saved. So here I’m sharing these examples because I believe that the power of AI is directly proportionate to the impact that we can have on lives saved, disease prevented, cost reduction, and therefore talking about cost reduction, the final one is really throughput optimization.

How can you be smarter about billing? How can you ensure that your patient has zero waiting time, that the data capture is using ambient systems, therefore the doctor is able to look at the patient and talk to the patient and you’re doing auto -population of your records. Millions of these capabilities are coming together. We’ve collated them. We’re getting MDSAP approval on almost 19 of them, FDA approval for nine, and we’re looking for partnership to build because I believe in this space. a thousand flowers can bloom, and that there is deeper work to be done on the use of our blood bank and our biobank with genetic testing to move further into disease prediction, biomarkers. So these are just new dimensions opening up.

And I’m sharing more of the examples of how we’re working in these areas, but before I go into those, I want to talk about the EASE framework. I’m happy that our EASE framework has been published fairly extensively because it talks about the ethical considerations of the use of AI. It looks at adoption, the suitability of a certain algorithm within the area that it’s being used, and finally the explainability so that every healthcare worker is able to understand what they use in which environment and what the interpretation means. I believe this is a base framework that we need to put into every healthcare environment. Moving on is another area of deep passion, and that is that while we’re doing the highest end of surgeries, curative care, transplants, etc.

How much can we spend our time on health care prevention? Because for every life -saving intervention, for every 1 ,000 people screened, you will have 11 people where you have averted a major crisis. And therefore, the ability to look at proactive preventive care and get a lot more intuitive on the mechanism of biomarkers and early detection in cancer. We are working with the ultrasound company to do an embedded AI into the ultrasound machine so that we can pick up NAFLD, non -alcoholic fatty liver, of which 40 % of the adult population of India is susceptible to. And if you can pick it up early, you can completely prevent a major crisis if you find it late. These are candidates for liver transplant, a lot of pain and suffering, and some of them potential death.

So the interventions at the appropriate time using technology open up an entire… realm of what we can do differently in this world. I’m sharing now this aspect of how lifestyle changes risk reduction. All of you on Instagram are getting thousands of messages a day on what to eat, how to exercise, what to do better. But is it quantified? Is there a risk scoring? Do you understand the difference between a high -risk group and what they need to do to a low -risk group? But every single group, by understanding the risk profiling and the modifiable risk factors of these non -communicable disease can move into a healthy pattern. This has been studied in partnership with Solventum, the company with 3M, with definitive proof on the power of doing something like this.

We also have a significant product on AI prediabetes which I think we’ve used for a long time. We’ve used it for a long time. We’ve used it for a long time. We’ve used this algorithm over 450 ,000 people. But I would love to see the 85 million diabetics in our country using this to predict and to handle their diabetes better. I also want to move on to the fact that in radiology, because of the years of data and the teleradiology services that we do across the world, we are able to take these images, and here we’ve worked with Google on prediction of tuberculosis in a simple x -ray. We’re working with various other companies, whether it’s an early detection of a brain bleed.

So once somebody goes into the emergency room, you’re quickly able to diagnose these. Each one of these are amazing new factors which are coming in. This is a quick example of the clinician co -pilot. Because I’m running out of time, I’m not going to share this video, but basically… Okay, they are playing the video. Can we have some volume on this? Or I’ll click through, because we’re really running out of time. But basically what the clinician co -pilot does is it’s synthesizing the record so that you’re summarizing. We’re approximately saving… We’re saving one to one and a half hours per day of doctor time in the records. We’re now doing the nurse pilot. I’m moving now to reimagining the way patients are monitored, whether it’s the challenge of a misdiagnosis, the integrated solution, which is looking at Care Console, and the technology stack around this, which is connecting the command station with the ICUs, with home, and with connected wards.

And because of this, we’ve not only saved millions of lives, we’ve saved time for doctors, and this is connected even to external nursing homes in small rural areas. I believe this is a powerful solution where the current AI algorithm has multiple factors from antibiotic usage to early warning symptoms of sepsis, but there are potentially another hundred algorithms that we could add on to this to enhance the quality of decision -making. And share this further, enabling a safer patient care and also less burnout in our staff. I’ve been sharing lots of hospital -based examples, but I do want to say that many of the solutions are applicable in rural India. We’re running mobile vans, we’re doing non -communicable disease screening in small rural environments, we’re finding ways to do cancer screening, tele -ophthalmology screening, and sharing this data and enabling either the ASHA worker or the district health authorities or even the government hospitals to diagnose faster, better, cheaper, and earlier.

And this is really the power of what can be done through early screening. I also do want to say, because for those who are listening from research organizations, from pharmaceuticals, from manufacturing, that we are among the people doing the largest number of validations. So innovation happens from multiple quarters, but validation is what moves a pilot into a mainstream activity. And that is what is critical for our country because you’ve been hearing this over the last two days about the number of pilots happening, but we’re not finding ways to continue this. I believe the hospital of the future is interconnected in multiple ways, from the theatres to the ICUs to using drone delivery. But then as we were drawing and designing this, we actually said, no, our thinking is too small and narrow.

We need to think bigger because the world is more connected. And primary care, preventive care, out there in the market, home care, these are the important redefinition factors of the future of healthcare. And so now I talk not about hospitals of the future, but about health systems of the future. This is what we need to redefine, and we have to do this together. These health systems of the future connect public and private, connect primary care with advanced care, connect research institutions, universities, innovators, health tech startups, all together to build new solutions for the betterment of healthcare. And I believe that this is a flywheel which will drive not just positive health productivity and the economics of the healthcare environment, but this data will enhance into new algorithms.

And these algorithms can be predictive and preventive, and if you find disease earlier, you’re actually saving so many aspects. So let us remove skill gaps. Let us push through regulatory gaps. Let us bring companies, organizations, and people together to build a new healthcare world, which is predictive, preventive, personalized, participatory, and place agnostic. Let every village in any part of the world, or every city, or every apartment building, wherever you are, be able to access good clinical care. Let’s come together to build a healthier world. And definitely, let’s say that this is the time for us to… to dream of finding cures for cancer, of enabling the world to be healthier, and finding a methodology for us to say that we brought our next generation into a healthier world.

Thank you so much, and namaste. Thank you. Thank you.

Related ResourcesKnowledge base sources related to the discussion topics (10)
Factual NotesClaims verified against the Diplo knowledge base (4)
Confirmedhigh

“Dr Pratap Siredi recalled that his father founded the first Apollo hospital after returning from the United States roughly 43 years ago.”

The knowledge base notes that Dr Pratap Siredi mentioned his father brought Apollo Hospitals back from the U.S. almost 43 years ago, confirming the timeline and founder relationship [S14].

Confirmedhigh

“India has a talent pool of more than 600 000 AI engineers that together provide the scale and affordability needed to build a national, AI‑driven health‑care ecosystem.”

A source reports that India employs over 600 000 engineers, highlighting the size of the technical workforce that can support large-scale AI initiatives [S37].

Additional Contextmedium

“India’s systemic advantages include a large out‑of‑pocket payment market, rapid expansion of doctors and nurses, and a talent pool of more than 600 000 AI engineers.”

Beyond the engineer count, the knowledge base emphasizes India’s status as a strong AI growth market and its large engineering graduate output, providing broader context for the country’s systemic advantages for AI deployment [S37] and [S38].

Confirmedmedium

“He introduced the EASE framework – Ethical, Adoption, Suitability, Explainability – as a baseline governance model for AI deployments.”

The EASE framework is explicitly referenced in the knowledge base as a published model covering ethical considerations, adoption, suitability and explainability of AI in health-care [S35].

External Sources (43)
S1
Keynote-Martin Schroeter — -Speaker 1: Role/Title: Not specified, Area of expertise: Not specified (appears to be an event moderator or host introd…
S2
Responsible AI for Children Safe Playful and Empowering Learning — -Speaker 1: Role/title not specified – appears to be a student or child participant in educational videos/demonstrations…
S3
Building Trusted AI at Scale Cities Startups & Digital Sovereignty – Keynote Vijay Shekar Sharma Paytm — -Speaker 1: Role/Title: Not mentioned, Area of expertise: Not mentioned (appears to be an event host or moderator introd…
S4
WS #53 Promoting Children’s Rights and Inclusion in the Digital Age — Speaker 1: Yes. So hi, everyone. When we talk about child rights online, so I’m gonna bring in a little bit from th…
S5
(Interactive Dialogue 4) Summit of the Future – General Assembly, 79th session — Inter American Development Bank: Excellencies. Dear delegates, the topics covered here today have impact that transcen…
S6
CSTD open consultation on WSIS+20 — Startups are developing payment solutions through wallets.
S7
Democratizing AI: Open foundations and shared resources for global impact — Mary-Anne Hartley: Yeah, sure. I think what we all saw with the use case over there is what is possible when people work…
S8
Building Climate-Resilient Systems with AI — Speaker 1 calls for a fundamental shift in how the academic and research community approaches climate solutions, moving …
S9
Open Forum #33 Building an International AI Cooperation Ecosystem — Participant: ≫ Distinguished guests, dear friends, it is a great honor to speak to you today on a topic that is reshapin…
S11
Skilling and Education in AI — In two significant areas, one is in agriculture, which is the highest employer, biggest employer anywhere. It’s also one…
S12
Conversational AI in low income & resource settings | IGF 2023 — Sameer Pujari:Thank you, Rajendra. And you rightly said all the member states are actually getting very excited about th…
S13
Keynote by Sangita Reddy Joint Managing Director Apollo Hospitals India AI Impact Summit — The success of Apollo’s digital transformation is exemplified by Apollo 24-7, their comprehensive digital healthcare pla…
S14
Keynote by Sangita Reddy Joint Managing Director Apollo Hospitals India AI Impact Summit — And our market has rewarded us with the volumes that we see. Over 45 million users have come into this. and now we have …
S15
https://dig.watch/event/india-ai-impact-summit-2026/building-trusted-ai-at-scale-cities-startups-digital-sovereignty-keynote-kiran-mazumdar-shaw — I believe that nations that command the convergence of biology and AI, or what I like to call the convergence of biologi…
S16
TradeTech for Greener Supply Chains — This has resulted in improved efficiency, reduced bureaucracy, and cost savings in the clearance of goods. Notably, smal…
S17
https://dig.watch/event/india-ai-impact-summit-2026/building-trusted-ai-at-scale-cities-startups-digital-sovereignty-keynote-ananya-birla-birla-ai-labs — Freeing over 2 ,000 man days a year. The immediate impact is efficiency. Architects and developers are no longer constra…
S18
AI Innovation in India — Bagla articulated a compelling vision of India’s unique advantages in the global AI landscape, asserting that India will…
S19
WS #288 An AI Policy Research Roadmap for Evidence-Based AI Policy — The roadmap is built upon core principles including “human and planetary welfare, accountability and transparency, inclu…
S20
Artificial intelligence (AI) – UN Security Council — Algorithmic transparency is a critical topic discussed in various sessions, notably in the9821st meetingof the AI Securi…
S21
WSIS Action Line C2 Information and communication infrastructure — Data quality and governance as fundamental requirements Legal and regulatory | Human rights Regulatory Frameworks and …
S22
AI for Bharat’s Health_ Addressing a Billion Clinical Realities — Soi explains that while the long-term goal is institutional adoption where AI becomes intrinsic to the organization, cur…
S23
MedTech and AI Innovations in Public Health Systems — Discussion point:Cost Reduction and Efficiency in Healthcare Delivery Discussion point:Preventive Healthcare and Popula…
S24
Keynote by Sangita Reddy Joint Managing Director Apollo Hospitals India AI Impact Summit — Dr. Reddy argues that India’s healthcare system has structural advantages that position it well for innovation. The high…
S25
AI Innovation in India — This comment energized the discussion by providing a grand vision that contextualized all the individual innovations wit…
S26
AI Innovation in India — Bagla articulated a compelling vision of India’s unique advantages in the global AI landscape, asserting that India will…
S27
Keynote by Sangita Reddy Joint Managing Director Apollo Hospitals India AI Impact Summit — And approximately now we have about 3 .5 million API calls on our AI platforms. These platforms we’ve divided into five …
S28
Artificial intelligence (AI) – UN Security Council — Algorithmic transparency is a critical topic discussed in various sessions, notably in the9821st meetingof the AI Securi…
S29
Ethics and AI | Part 6 — Even if the Act itself does not make direct reference to “ethics”, it is closely tied to the broader context of ethical …
S30
Day 0 Event #173 Building Ethical AI: Policy Tool for Human Centric and Responsible AI Governance — Chris Martin: Thanks, Ahmed. Well, everyone, I’ll walk through I think a little bit of this presentation here on what…
S31
MedTech and AI Innovations in Public Health Systems — Discussion point:Cost Reduction and Efficiency in Healthcare Delivery Discussion point:Preventive Healthcare and Popula…
S32
Leaders TalkX: Looking Ahead: Emerging tech for building sustainable futures — The speech concluded with a critical reflection on the urgent necessity to tackle health-related misinformation, a matte…
S33
(Interactive Dialogue 3) Summit of the Future – General Assembly, 79th session — Amanuel Giorgio : Thank you, Co-Chairs. In an era marked by unprecedented global challenges, the need for collective …
S34
Cracking the Code of Digital Health / DAVOS 2025 — – Shobana Kamineni: Executive Chairperson, Apollo Health Company Karen Tso: Distinguished guests, ladies and gentlemen…
S35
https://app.faicon.ai/ai-impact-summit-2026/keynote-by-sangita-reddy-joint-managing-director-apollo-hospitals-india-ai-impact-summit — And I’m sharing more of the examples of how we’re working in these areas, but before I go into those, I want to talk abo…
S36
Keynote-Bejul Somaia — In healthcare, Somaia outlined how AI will break the current equation where quality care is rationed by geography and in…
S37
Building Trusted AI at Scale Cities Startups & Digital Sovereignty – Panel Discussion Moderator Amitabh Kant NITI — Thanks. Thanks. Thanks for that. I just wanted to turn to Mr. Christy Wilson because he’s the biggest employer in India….
S38
Building Trusted AI at Scale Cities Startups & Digital Sovereignty – Keynote Hemant Taneja General Catalyst — Taneja argued that India is uniquely positioned to lead in AI deployment due to its status as the world’s strongest grow…
S39
Building Trusted AI at Scale Cities Startups & Digital Sovereignty – Keynote Giordano Albertazzi — Albertazzi positioned India as central to the AI evolution, citing several key advantages that make the country particul…
S40
Researchers for OpenAI and Apollo find scheming behaviour in frontier AI models — OpenAI and Apollo Researchdevelopedevaluations to reveal hidden misalignment in advanced AI systems, often labelled sche…
S41
AI and Global Power Dynamics: A Comprehensive Analysis of Economic Transformation and Geopolitical Implications — Actually, clearly in the first group, and the reason for that is there are five layers in the AI architecture. The appli…
S42
AI for Bharat’s Health_ Addressing a Billion Clinical Realities — Between patient and interoperability will start impacting the clinical decision making for the physician. going forward….
S43
MedTech and AI Innovations in Public Health Systems — And I’m going to do that. be within the delivery thing, not as a layer on top. And if you then, if we focus on, you know…
Speakers Analysis
Detailed breakdown of each speaker’s arguments and positions
S
Speaker 1
19 arguments152 words per minute2092 words825 seconds
Argument 1
High out‑of‑pocket payments drive innovation and low‑cost solutions (Speaker 1)
EXPLANATION
India’s high out‑of‑pocket health expenditures create pressure to develop cost‑effective innovations. This financial reality is presented as a catalyst for low‑cost solutions in the healthcare system.
EVIDENCE
The speaker notes that India has one of the highest out-of-pocket payment levels, which forces the creation of innovation while keeping costs low [4].
MAJOR DISCUSSION POINT
Innovation driven by out‑of‑pocket spending
Argument 2
Growing doctor, nurse, and AI talent pool enables large‑scale impact (Speaker 1)
EXPLANATION
The expansion of medical professionals and AI engineers provides the human capital needed for nationwide health initiatives. A large talent pool is positioned as a strategic advantage for scaling AI‑enabled care.
EVIDENCE
The speaker highlights that India is training more doctors, more nurses, and possesses a talent pool of over 600,000 AI engineers, supporting large-scale impact [4].
MAJOR DISCUSSION POINT
Talent pool as a scalability factor
Argument 3
Enables medicine purchase, diagnostics ordering, health‑record storage, and AI‑driven assistance (Speaker 1)
EXPLANATION
Apollo 24‑7 functions as a digital front‑door where patients can order medicines, request diagnostics, keep health records, and interact with an AI assistant. This platform integrates multiple patient services into a single ecosystem.
EVIDENCE
The speaker describes Apollo 24-7 allowing users to buy medicines, order diagnostics, store health records, and ask queries via Apollo Assist [12].
EXTERNAL EVIDENCE (KNOWLEDGE BASE)
Apollo 24-7 is described as a digital front-door that lets patients buy medicines, order diagnostics, store health records and interact with an AI assistant, matching this claim [S13][S14].
MAJOR DISCUSSION POINT
Comprehensive digital patient portal
Argument 4
Over 45 million users with ~1 million daily interactions demonstrate market adoption (Speaker 1)
EXPLANATION
High user numbers illustrate strong market acceptance of the digital health platform. Daily active usage underscores the ecosystem’s relevance to a large population.
EVIDENCE
The speaker reports more than 45 million total users and close to a million daily interactions on the platform [14].
EXTERNAL EVIDENCE (KNOWLEDGE BASE)
The platform’s adoption numbers-over 45 million total users and close to a million daily interactions-are reported in the keynote material [S13][S14].
MAJOR DISCUSSION POINT
Scale of user adoption
Argument 5
Clinical intelligence engine aggregates 20 million doctor records for decision support (Speaker 1)
EXPLANATION
A clinical intelligence engine consolidates extensive doctor‑generated data to provide decision‑support tools for clinicians. This data‑driven approach aims to enhance diagnostic accuracy and treatment planning.
EVIDENCE
The speaker explains that the clinical intelligence engine includes a cumulative doctor workforce of about 20 million records analyzed for decision support [21-23].
EXTERNAL EVIDENCE (KNOWLEDGE BASE)
The clinical intelligence engine that analyses roughly 20 million doctor-generated records for decision-support is detailed in the Apollo presentation [S13][S14].
MAJOR DISCUSSION POINT
Data‑driven clinical decision support
Argument 6
Disease‑risk prediction models target cardiac, diabetes, hypertension, etc., for population‑level focus (Speaker 1)
EXPLANATION
Predictive models generate risk scores for major non‑communicable diseases, helping prioritize interventions across India’s 1.4 billion population. The focus is on high‑impact disease categories.
EVIDENCE
The speaker outlines disease prediction and risk scoring across cardiac, diabetes, hypertension and other conditions to guide population-level focus [24-27].
EXTERNAL EVIDENCE (KNOWLEDGE BASE)
Disease-risk prediction and risk-scoring covering cardiac disease, diabetes, hypertension and other conditions are outlined in the same source [S13][S14].
MAJOR DISCUSSION POINT
Population‑level risk stratification
Argument 7
Multimodal AI extracts insights from images and physiological signals to aid diagnosis (Speaker 1)
EXPLANATION
AI systems combine imaging and signal data to produce richer clinical interpretations than any single modality. This multimodal analysis is intended to support clinicians with more accurate diagnoses.
EVIDENCE
The speaker describes taking images and signals, synthesizing them smarter than any individual, and converting multimodal signaling into causal interpretation for doctors [27-28].
EXTERNAL EVIDENCE (KNOWLEDGE BASE)
The platform’s multimodal AI that combines imaging and signal data for richer clinical interpretation is described in the keynote [S13][S14].
MAJOR DISCUSSION POINT
Multimodal AI for diagnostic insight
Argument 8
Early‑warning system predicts sepsis 24–48 hours before onset in ICU beds (Speaker 1)
EXPLANATION
An AI‑driven early warning algorithm monitors ICU patients and forecasts sepsis well before clinical manifestation, potentially saving lives. The system is deployed across thousands of critical‑care beds.
EVIDENCE
The speaker notes that about 2,000 critical-care beds are linked to an early-warning symptom system that predicts sepsis 24 to 48 hours before it happens [30-32].
MAJOR DISCUSSION POINT
Proactive sepsis prediction
Argument 9
Throughput optimization automates billing, reduces waiting time, and auto‑populates records (Speaker 1)
EXPLANATION
AI is used to streamline operational workflows, including billing automation, eliminating patient wait times, and automatically filling electronic records. These efficiencies aim to improve both patient experience and provider productivity.
EVIDENCE
The speaker mentions smarter billing, ensuring zero waiting time, and auto-population of records using ambient systems so doctors can focus on patient interaction [35-36].
EXTERNAL EVIDENCE (KNOWLEDGE BASE)
Throughput-optimization features such as smarter billing, zero waiting time and automatic record population are mentioned in the Apollo AI overview [S13][S14].
MAJOR DISCUSSION POINT
Operational efficiency via AI
Argument 10
Clinician co‑pilot saves 1–1.5 hours of doctor time per day by summarizing records (Speaker 1)
EXPLANATION
The clinician co‑pilot tool condenses patient records, freeing up significant clinician time each day. This time saving can be redirected to direct patient care.
EVIDENCE
The speaker explains that the clinician co-pilot synthesizes records, saving approximately one to one and a half hours of doctor time per day [72-74].
MAJOR DISCUSSION POINT
Time savings for clinicians
Argument 11
EASE outlines ethical use, suitability assessment, and explainability for AI in healthcare (Speaker 1)
EXPLANATION
The EASE framework provides guidelines for ethical AI deployment, assessing algorithm suitability, and ensuring explainability for healthcare workers. It is positioned as a foundational governance model.
EVIDENCE
The speaker details that the EASE framework covers ethical considerations, adoption, suitability, and explainability so every healthcare worker can understand AI usage [41-43].
MAJOR DISCUSSION POINT
Ethical AI governance
Argument 12
Embedded AI in ultrasound detects NAFLD early, preventing liver failure (Speaker 1)
EXPLANATION
AI integrated into ultrasound devices can identify non‑alcoholic fatty liver disease at an early stage, allowing timely intervention to avoid severe liver complications. Early detection is framed as a preventive strategy.
EVIDENCE
The speaker states that an embedded AI in ultrasound can pick up NAFLD, which affects 40 % of Indian adults, and early detection can completely prevent a major crisis [47-48].
MAJOR DISCUSSION POINT
Early liver disease detection
Argument 13
AI‑based pre‑diabetes tool has screened 450 000 people; scaling to 85 million diabetics is envisioned (Speaker 1)
EXPLANATION
An AI algorithm for pre‑diabetes risk assessment has already been applied to hundreds of thousands of individuals, with plans to extend its reach to the nation’s 85 million diabetics. The goal is large‑scale preventive management.
EVIDENCE
The speaker notes that the algorithm has been used for over 450,000 people and expresses the desire to reach 85 million diabetics in India [61-63].
MAJOR DISCUSSION POINT
Scaling pre‑diabetes AI screening
Argument 14
Partnership with Google enables AI detection of tuberculosis from X‑rays (Speaker 1)
EXPLANATION
Collaboration with Google has produced an AI model that can identify tuberculosis on standard chest X‑rays, facilitating rapid diagnosis. This exemplifies leveraging external expertise for disease detection.
EVIDENCE
The speaker mentions working with Google on AI prediction of tuberculosis from a simple X-ray [63].
MAJOR DISCUSSION POINT
AI‑assisted TB diagnosis
Argument 15
Additional AI models identify brain bleeds and other emergencies quickly (Speaker 1)
EXPLANATION
Beyond TB, the organization is developing AI tools for rapid identification of acute conditions such as brain bleeds, enabling faster emergency response. These models expand the AI portfolio for critical care.
EVIDENCE
The speaker references work with various companies on early detection of brain bleeds and other emergencies, allowing quick diagnosis in the ER [64-66].
MAJOR DISCUSSION POINT
Rapid AI detection of acute emergencies
Argument 16
Mobile vans conduct non‑communicable disease, cancer, and tele‑ophthalmology screening in remote areas (Speaker 1)
EXPLANATION
Mobile health units travel to rural locations to screen for NCDs, cancer, and eye diseases via tele‑ophthalmology, extending services beyond urban centers. This outreach aims to reduce geographic health disparities.
EVIDENCE
The speaker describes running mobile vans that perform non-communicable disease screening, cancer screening, and tele-ophthalmology in small rural environments [80].
MAJOR DISCUSSION POINT
Rural mobile health outreach
Argument 17
Data shared with ASHA workers and district health authorities improves rural diagnostics (Speaker 1)
EXPLANATION
Collected health data from mobile screenings is transmitted to community health workers (ASHA) and district authorities, enhancing diagnostic speed and accuracy in rural settings. Data sharing is presented as a key enabler for better care.
EVIDENCE
The speaker notes that sharing this data enables ASHA workers or district health authorities to diagnose faster, better, cheaper, and earlier [80-81].
MAJOR DISCUSSION POINT
Data empowerment for rural health workers
Argument 18
Extensive validation (MDSAP, FDA approvals) moves pilots to mainstream use (Speaker 1)
EXPLANATION
Regulatory approvals such as MDSAP and FDA are cited as evidence that AI solutions have passed rigorous validation, facilitating transition from pilot projects to widespread deployment. Validation is portrayed as essential for scaling.
EVIDENCE
The speaker reports obtaining MDSAP approval on almost 19 solutions and FDA approval for nine, indicating extensive validation [38].
MAJOR DISCUSSION POINT
Regulatory validation for scaling
Argument 19
Call for unified health system linking public/private, primary/advanced care, research, and startups to create a predictive, preventive, personalized, participatory, place‑agnostic ecosystem (Speaker 1)
EXPLANATION
The speaker advocates for an integrated health system that connects public and private sectors, primary and advanced care, and innovation ecosystems to deliver holistic, data‑driven health services. The vision emphasizes a future where care is predictive, preventive, personalized, participatory, and location‑independent.
EVIDENCE
The speaker describes a future health system that connects hospitals, primary care, research institutions, universities, innovators, and health-tech startups, creating a flywheel for productivity, economics, and new predictive algorithms, and calls for removing skill and regulatory gaps to achieve this vision [85-92][95-98].
MAJOR DISCUSSION POINT
Integrated, future‑oriented health ecosystem
Agreements
Agreement Points
Similar Viewpoints
Unexpected Consensus
Overall Assessment

The transcript contains remarks from a single participant (Speaker 1) who presents a cohesive set of arguments about AI‑enabled healthcare in India. Because no other speakers are present, there are no cross‑speaker agreement points, shared viewpoints, or surprising consensuses to report.

No multi‑speaker consensus can be assessed; the discussion reflects a single perspective that is internally consistent but does not reveal agreement or divergence among multiple participants.

Differences
Different Viewpoints
Unexpected Differences
Overall Assessment

The transcript contains only statements from Speaker 1, with no other participants presenting contrasting views. Consequently, there are no identifiable points of disagreement, partial agreement, or unexpected disagreement within the discussion.

No disagreement detected; the discussion reflects a single perspective, implying consensus or lack of debate on the presented topics.

Takeaways
Key takeaways
India can leverage its large out‑of‑pocket health‑care market, growing clinical workforce, and 600,000‑strong AI talent pool to create scalable, low‑cost health solutions. Apollo 24‑7 serves as a digital front‑door, offering medicine ordering, diagnostics, health‑record storage and AI‑driven assistance, with >45 million users and ~1 million daily interactions. A comprehensive AI platform supports clinical intelligence (20 M doctor records), disease‑risk prediction (cardiac, diabetes, hypertension), multimodal imaging and signal analysis, and acute‑care early‑warning (sepsis prediction 24‑48 h ahead). AI improves operational efficiency through throughput optimisation, automated billing, auto‑population of records, and a clinician co‑pilot that saves 1–1.5 hours of physician time per day. The EASE framework (Ethical, Adoption, Suitability, Explainability) is proposed as a baseline for responsible AI deployment in health‑care. Preventive care is emphasized: AI‑embedded ultrasound for early NAFLD detection, AI pre‑diabetes screening (450 k screened, goal 85 M), and risk‑scoring for lifestyle interventions. Strategic radiology collaborations (e.g., with Google) enable rapid AI detection of TB, brain bleeds and other emergencies. Rural outreach via mobile vans, tele‑ophthalmology, and data sharing with ASHA workers extends advanced diagnostics to remote populations. Extensive validation (MDSAP, FDA) is critical to move pilots to mainstream; a call for unified health‑system integration across public/private, primary/advanced care, research, and startups. Vision for a future health ecosystem that is predictive, preventive, personalized, participatory and place‑agnostic, removing skill and regulatory gaps.
Resolutions and action items
Seek partnerships with technology firms, research institutions, pharma and startups to co‑develop and scale AI solutions (e.g., expanding the sepsis early‑warning algorithm to 100,000 ICU beds). Scale the AI pre‑diabetes tool from 450 k users to the estimated 85 million diabetics in India. Expand mobile‑van screening programs and tele‑ophthalmology services to additional rural districts, integrating data with ASHA workers and district health authorities. Continue validation and regulatory approval processes (MDSAP, FDA) for the 19 AI tools under review to transition them from pilots to standard care. Implement the EASE framework across all AI deployments to ensure ethical use, suitability assessment, and explainability for clinicians. Develop a unified health‑system platform that links public and private providers, primary and tertiary care, research bodies, and health‑tech innovators. Promote throughput‑optimization initiatives (automated billing, record auto‑population) across hospital networks to reduce wait times and clinician burden.
Unresolved issues
How to effectively close the regulatory and skill gaps that hinder rapid AI adoption at scale. Funding and logistical pathways for deploying AI‑enabled early‑warning systems to hundreds of thousands of ICU beds nationwide. Mechanisms for sustained data sharing and interoperability between private hospital systems, public health agencies, and rural health workers. Ensuring equitable access to high‑cost technologies (e.g., surgical robots, proton therapy) for underserved populations beyond digital solutions. Long‑term governance and monitoring of AI ethics and explainability once the EASE framework is adopted.
Suggested compromises
Balancing high‑end curative interventions with a stronger focus on preventive care to maximise population health impact. Adopting the EASE framework as a compromise between rapid AI innovation and the need for ethical, transparent, and explainable deployment. Integrating AI decision‑support tools as co‑pilots rather than replacements for clinicians, preserving human oversight while improving efficiency.
Thought Provoking Comments
India and that your health care should not be defined by the zip code in which you’re born. It’s about sustainable costs and it’s about preventive care and early detection.
Sets a bold, equity‑focused premise that reframes health‑care quality as a universal right rather than a geographic lottery, challenging the common assumption that location dictates access.
Establishes the overarching theme of the talk and primes the audience to view all subsequent technology examples through the lens of equity and prevention, steering the conversation toward systemic change.
Speaker: Speaker 1
We have the largest talent pool of over 600,000 AI engineers… I’m not here to talk to you about technology. I’m here to share our story… using every tool possible to bring health care within the reach of people.
Combines a factual claim about India’s AI talent with a personal narrative, linking human capital to mission‑driven storytelling rather than pure tech hype.
Creates a turning point from abstract tech talk to a concrete, mission‑oriented narrative, making the audience consider how talent can be mobilized for social impact.
Speaker: Speaker 1
Apollo 24‑7, our digital front door, lets you buy medicines, order diagnostics, store health records, ask queries via Apollo Assist, and interact with an ecosystem that now serves over 45 million users.
Illustrates a tangible, patient‑centric platform that integrates multiple services, moving the discussion from high‑level vision to a real‑world implementation that scales.
Shifts the conversation toward scalability and user adoption, prompting listeners to think about digital infrastructure as a foundation for broader AI initiatives.
Speaker: Speaker 1
Our clinical intelligence engine gives a new doctor the cumulative knowledge of 20 million records, and our disease‑prediction risk scores let us focus interventions for a 1.4 billion‑person population.
Highlights how AI can amplify clinical expertise and enable population‑level targeting, introducing the concept of data‑driven precision at national scale.
Introduces a new analytical dimension—population health management—steering the dialogue toward how AI can prioritize resources and reshape public‑health strategy.
Speaker: Speaker 1
We are predicting the onset of sepsis 24 to 48 hours before it happens. Imagine if we could put this AI algorithm into a hundred thousand ICU beds.
Provides a concrete, high‑impact use case that quantifies potential lives saved, making the abstract benefits of AI vivid and urgent.
Creates an emotional and logical pivot, compelling the audience to envision large‑scale clinical outcomes and reinforcing the argument for rapid deployment.
Speaker: Speaker 1
Our EASE framework—Ethical considerations, Adoption, Suitability, Explainability—must be embedded in every healthcare AI deployment.
Introduces a structured ethical lens at a moment when technical achievements dominate, challenging the audience to consider governance alongside innovation.
Marks a turning point from showcasing capabilities to addressing responsibility, prompting listeners to think about regulatory and trust issues.
Speaker: Speaker 1
For every life‑saving intervention, screening 1,000 people averts a major crisis in 11 of them. Early detection of NAFLD via AI‑embedded ultrasound could prevent liver transplants for millions.
Shifts focus from curative to preventive care, using striking statistics to argue that early detection yields disproportionate health and cost benefits.
Redirects the conversation toward preventive strategies, influencing the audience to prioritize screening programs and rural outreach.
Speaker: Speaker 1
We are running mobile vans, tele‑ophthalmology, and ASHA‑enabled screening in rural India, and we are among the largest validators of AI pilots, turning them into mainstream activity.
Connects high‑tech solutions with grassroots delivery and emphasizes validation as the bridge from pilot to impact, challenging the notion that AI is only for elite hospitals.
Broadens the scope of the discussion to include implementation pathways in low‑resource settings, reinforcing the earlier equity theme.
Speaker: Speaker 1
The hospital of the future is not a building; it is an interconnected health system that links public and private, primary and advanced care, research, startups, and patients—creating a predictive, preventive, personalized, participatory, place‑agnostic ecosystem.
Synthesizes all prior points into a visionary systems‑level model, reframing health care as a networked ecosystem rather than isolated institutions.
Serves as the concluding turning point, unifying technology, ethics, prevention, and collaboration into a single strategic vision that calls the audience to collective action.
Speaker: Speaker 1
Overall Assessment

Speaker 1’s monologue weaves together data, personal story, and visionary concepts, using a series of strategically placed insights that repeatedly shift the conversation’s focus—from equity and talent, to digital platforms, to AI‑driven clinical intelligence, to life‑saving predictive models, to ethical governance, and finally to a holistic, interconnected health‑system vision. Each pivotal comment not only introduced a fresh dimension but also redirected audience attention, deepening the analysis and building momentum toward a call for collaborative, system‑wide transformation. Collectively, these moments shaped the discussion from a descriptive showcase of technology into a compelling narrative about how AI, when ethically grounded and broadly deployed, can redefine health care for all of India and beyond.

Follow-up Questions
Exploring partnerships to co‑develop AI solutions for healthcare delivery
Collaboration is needed to scale AI tools across hospitals and rural settings, ensuring broader impact and shared expertise.
Speaker: Speaker 1 (Dr. Pratap Siredi)
Deepening work on blood‑bank and biobank integration with genetic testing for disease prediction and biomarker discovery
Genetic data could enhance early detection models and personalize preventive strategies, but requires research on feasibility and validation.
Speaker: Speaker 1 (Dr. Pratap Siredi)
Systematic validation of AI pilots to transition them into mainstream clinical practice
Large‑scale validation is essential to prove efficacy, safety, and cost‑effectiveness before widespread adoption.
Speaker: Speaker 1 (Dr. Pratap Siredi)
Development and integration of additional AI algorithms (potentially hundreds) for ICU decision‑making, beyond sepsis prediction
Expanding the algorithm portfolio could further reduce mortality and staff burnout, but requires research on algorithm selection, integration, and outcomes.
Speaker: Speaker 1 (Dr. Pratap Siredi)
Scaling the AI pre‑diabetes tool to reach all 85 million diabetics in India
Widespread deployment could improve disease management, yet needs studies on implementation logistics, user engagement, and impact on health outcomes.
Speaker: Speaker 1 (Dr. Pratap Siredi)
Embedding AI into ultrasound devices for early detection of non‑alcoholic fatty liver disease (NAFLD)
Early NAFLD detection could prevent liver failure, but requires technical development, accuracy testing, and workflow integration research.
Speaker: Speaker 1 (Dr. Pratap Siredi)
Quantifying lifestyle‑change interventions through risk‑scoring models for non‑communicable diseases
Understanding how risk scores translate into behavior change is needed to validate digital health coaching effectiveness.
Speaker: Speaker 1 (Dr. Pratap Siredi)
Addressing regulatory gaps to accelerate AI adoption in Indian healthcare
Research into policy frameworks and compliance pathways will help streamline approvals and ensure patient safety.
Speaker: Speaker 1 (Dr. Pratap Siredi)
Designing interoperable health‑system architectures that connect public and private sectors, primary and advanced care, and research institutions
A unified ecosystem could enhance data sharing and care continuity, but demands investigation into standards, governance, and scalability.
Speaker: Speaker 1 (Dr. Pratap Siredi)
Leveraging accumulated health data to develop next‑generation predictive and preventive AI algorithms
Continuous learning from real‑world data can improve model performance; research is needed on data quality, privacy, and model updating.
Speaker: Speaker 1 (Dr. Pratap Siredi)
Evaluating the impact of AI‑driven clinician co‑pilot tools on physician time savings and diagnostic accuracy
Preliminary claims of 1–1.5 hours saved per day require rigorous study to confirm efficiency gains and patient safety outcomes.
Speaker: Speaker 1 (Dr. Pratap Siredi)
Assessing the effectiveness of mobile van screening programs for non‑communicable diseases and tele‑ophthalmology in rural India
Research is needed to measure reach, diagnostic yield, cost‑effectiveness, and integration with local health workers and authorities.
Speaker: Speaker 1 (Dr. Pratap Siredi)

Disclaimer: This is not an official session record. DiploAI generates these resources from audiovisual recordings, and they are presented as-is, including potential errors. Due to logistical challenges, such as discrepancies in audio/video or transcripts, names may be misspelled. We strive for accuracy to the best of our ability.